Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5142181 | 0.77 | KMT2A (0.33) | KMT2AALDH1A1GLAHPGDPLAU | |
| SCHEMBL28593483 | 0.77 | — | — | |
| SCHEMBL791025 | 0.76 | AGBL2 (0.36) | KMT2AALDH1A1HPGDKDM4EPOLB | |
| SCHEMBL7968781 | 0.76 | HTT (0.34) | — | |
| SCHEMBL28713868 | 0.76 | NOS3 (0.36) | KMT2AALDH1A1PLAUKDM4EPOLB | |
| SCHEMBL4472993 | 0.76 | TRPV1 (0.31) | — | |
| SCHEMBL790734 | 0.76 | ALDH1A1 (0.40) | KMT2AALDH1A1GLAHPGDPLAU | |
| SCHEMBL17979223 | 0.71 | — | — | |
| SCHEMBL21810854 | 0.71 | SMN1; SMN2 (0.37) | KMT2AHPGDKDM4ESMN1; SMN2AGBL2 | |
| SCHEMBL28887006 | 0.71 | KIF11 (0.33) | KMT2APOLBAGBL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041854-A1 | COLD MEDICINE AND ANTIVIRAL MEDICINE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2024-02-08 | — | — | US | disclosed |
| EP-4190329-A1 | COLD REMEDY AND ANTIVIRAL AGENT | Otsuka Pharmaceutical Factory, Inc. (JP) | 2023-06-07 | — | — | EP | disclosed |
| EP-1417202-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2004-05-12 | — | — | EP | disclosed |
| US-20030069276-A1 | Amino piperidine derivatives | F.HOFFMANN-LA ROCHE AG (CH) | 2003-04-10 | — | — | US | disclosed |
| WO-2002079186-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2002-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041854-A1 | COLD MEDICINE AND ANTIVIRAL MEDICINE | IRF3, MAVS, EIF2AK2 | KMT2A 3581/4885ALDH1A1 1236/4885GLA 2317/4885 |
| US-20030069276-A1 | Amino piperidine derivatives | CCR5, CCR2, CXCR4 | KMT2A 3009/4885ALDH1A1 1935/4885GLA 4873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.